Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1075859
Max Phase: Preclinical
Molecular Formula: C43H57N7O5
Molecular Weight: 751.97
Molecule Type: Small molecule
Associated Items:
ID: ALA1075859
Max Phase: Preclinical
Molecular Formula: C43H57N7O5
Molecular Weight: 751.97
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N(C)CCc1ccccn1
Standard InChI: InChI=1S/C43H57N7O5/c1-3-4-5-6-7-8-9-13-19-40(52)47-38(29-35-30-44-31-46-35)42(54)48-37(27-32-16-11-10-12-17-32)41(53)49-39(28-33-20-22-36(51)23-21-33)43(55)50(2)26-24-34-18-14-15-25-45-34/h10-12,14-18,20-23,25,30-31,37-39,51H,3-9,13,19,24,26-29H2,1-2H3,(H,44,46)(H,47,52)(H,48,54)(H,49,53)/t37-,38-,39-/m0/s1
Standard InChI Key: KGRSUMUKTYCXCP-IGMOWHQGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 751.97 | Molecular Weight (Monoisotopic): 751.4421 | AlogP: 5.22 | #Rotatable Bonds: 24 |
Polar Surface Area: 169.41 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: 6.53 | CX LogP: 5.47 | CX LogD: 5.41 |
Aromatic Rings: 4 | Heavy Atoms: 55 | QED Weighted: 0.06 | Np Likeness Score: -0.36 |
1. Tan KT, Guiu-Rozas E, Bon RS, Guo Z, Delon C, Wetzel S, Arndt S, Alexandrov K, Waldmann H, Goody RS, Wu YW, Blankenfeldt W.. (2009) Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors., 52 (24): [PMID:19894725] [10.1021/jm901117d] |
Source(1):